acute myeloid leukemia
Potent activity of ponatinib (AP24534) in models of FLT3-driven acute myeloid leukemia and other hematologic malignancies.
Potent activity of ponatinib (AP24534) in models of <span class="gene" id="21482694-0-52-56">FLT3</span>-driven <span class="disease" id="21482694-0-64-86">acute myeloid leukemia</span> and other hematologic malignancies.